Syncona Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
16
- Investments
-
58
- Portfolio
-
16
- Exits
-
12
Syncona General Information
Company Description
Founded in 2012, Syncona is a venture capital firm based in London, United Kingdom. The firm seeks to invest in the healthcare sector.
Business Details
Website
www.synconaltd.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 8 Bloomsbury Street
- 2nd Floor
- London WC1B 3SR
- England, United Kingdom
Syncona Investments & Acquisitions (58)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Oyster Therapeutics | 10-Nov-2026 | Later Stage VC | Drug Discovery | Pre-Clinical Trials | ||
| OMass Therapeutics | 15-Oct-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Re-Aim Therapeutics | 18-May-2026 | Drug Discovery | Product Development | |||
| ALTx Therapeutics | 05-Feb-2026 | Drug Discovery | Startup | |||
| Beacon Therapeutics | 09-Jan-2026 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Purespring Therapeutics | 08-Oct-2024 | Drug Discovery | Pre-Clinical Trials | |||
| Resolution Therapeutics | 03-Oct-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Beacon Therapeutics | 03-Jul-2024 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Yellowstone Biosciences | 20-Jun-2024 | Early Stage VC | Discovery Tools (Healthcare) | Generating Revenue | ||
| iOnctura | 20-Jun-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 3 |
Syncona Exits (12)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| SwanBio Therapeutics | 25-Jun-2024 | Merger/Acquisition | |
| Clade Therapeutics | 11-Apr-2024 | ||
| Neogene Therapeutics | 16-Jan-2023 | ||
| Gyroscope | 17-Feb-2022 | ||
| Achilles Therapeutics | 31-Mar-2021 | ||
| Azeria Therapeutics | 08-Dec-2020 | ||
| Spur Therapeutics | 07-Aug-2020 | ||
| Blue Earth Diagnostics | 01-Aug-2019 | ||
| Autolus | 11-Apr-2019 | Public Investment 2nd Offering | |
| Autolus | 22-Jun-2018 | IPO |
Syncona Investments by Industry, Year, and Region
Syncona Co-Investors (40)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Oxford Science Enterprises | 4 |
|
|
||
| Forbion |
|
|
|||
| British Business Bank |
|
|
|||
| Cancer Research Technology |
|
|
|||
| Mass General Brigham Ventures |
|
|
Syncona Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Bidco 1354 | Stevenage, United Kingdom | 2023 | |
| Syncona Investment Management | London, United Kingdom | 2016 |
Syncona FAQs
-
What is Syncona?
Founded in 2012, Syncona is a venture capital firm based in London, United Kingdom.
-
When was Syncona founded?
Syncona was founded in 2012.
-
Where is Syncona headquartered?
Syncona is headquartered in London, United Kingdom.
-
What is Syncona's total asset value?
Syncona has around in total assets under management.
-
How many investments has Syncona made?
Syncona has made 58 investments.
-
What has Syncona invested in?
Syncona has made numerous investments in companies like Oyster Therapeutics, OMass Therapeutics, and Re-Aim Therapeutics within the Drug Discovery industry.
-
What has Syncona invested in recently?
Syncona's latest investment was on 10-Nov-2026 in Oyster Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process